BigpAK-2: A biomarker-guided preventive care bundle cut moderate or severe acute kidney injury after major surgery (2025) — Trial Summary

BigpAK-2: A biomarker-guided preventive care bundle cut moderate or severe acute kidney injury after major surgery (2025): Multinational, multicenter randomized clinical trial at 34 hospitals in Europe. Adults (18 years or older) admitted to intensive care after major surgery who were at high risk f

References

NephroResource

Taking longer than expected

If you're on a slow connection or this keeps happening, tap below to reload.